ArticleInfection and drug resistance2019
Multi-Drug Resistant
Article in Infection and drug resistance, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 35 citations in OpenAlex.
- Agent, Dose and Duration: The Unanswered Questions Behind Latency Antibiotic Therapy for Preterm Prelabour Rupture of Membranes.Antibiotics (Basel, Switzerland) · 2026Review
- Evaluation and Validation of a Loop-Mediated Isothermal Amplification (LAMP) Assay for Detection of Escherichia coli from Blood Samples of Young Infants with Sepsis.Indian journal of pediatrics · 2026Article
- Characteristics of Neonates with Sepsis Associated with Antimicrobial Resistance and Mortality in a Tertiary Hospital in Mexico: A Retrospective Observational Study.Pathogens (Basel, Switzerland) · 2025Observational
- Clinical and Antibiotic Resistance Features for Extended-Spectrum Betalactamase-ProducingInfection and drug resistance · 2025Article
- Detection of O25B-ST131 clone andPeerJ · 2025Article
- Therapeutic and Diagnostic Potential of a Novel K1 Capsule Dependent Phage, JSSK01, and Its Depolymerase in Multidrug-ResistantInternational journal of molecular sciences · 2024Article
- A live attenuated vaccine to prevent severe neonatal Escherichia coli K1 infections.Nature communications · 2024Article
- Pathogen Distribution of Neonatal Bacterial Meningitis in the Era of Multidrug-Resistant Bacteria: A Single-Center Experience.Infection and drug resistance · 2024Article
- Risk Factors Associated with Multi-Drug Resistance in Neonatal Sepsis Caused byInfection and drug resistance · 2023Article
- Pathogen Distribution and Antimicrobial Resistance of Early Onset Sepsis in Very Premature Infants: A Real-World Study.Infectious diseases and therapy · 2022Article
- [Sensitivity pattern of E. coli at the National Medical Center of Bajío].Revista medica del Instituto Mexicano del Seguro Social · 2022Article
- Sepsis Management in Southeast Asia: A Review and Clinical Experience.Journal of clinical medicine · 2022Review
- Antimicrobial Susceptibility Profiles Among Neonatal Early-onset Sepsis Pathogens.The Pediatric infectious disease journal · 2022Article
- Factors associated with in-hospital mortality in adult sepsis with Escherichia coli infection.BMC infectious diseases · 2022Article
- Etiology and clinical characteristics of neonatal sepsis in different medical setting models: A retrospective multi-center study.Frontiers in pediatrics · 2022Article
- A rapid evidence assessment exploring whether antimicrobial resistance complicates non-infectious health conditions and healthcare services, 2010-20.JAC-antimicrobial resistance · 2021Review
- Chorioamnionitis and neonatal sepsis due to extended-spectrum beta-lactamase-producingClinical case reports · 2021Article
- Article
- [Clinical features of very preterm infants with prelabor rupture of membranes and predictive factors for major adverse outcomes].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2021Article
- Vertical Transmission of Extended-Spectrum, Beta-Lactamase-ProducingMicroorganisms · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectiveInfections caused by extended-spectrum beta-lactamase (ESBL)-producing
methodsTwo periods, 2002 to 2008 and 2012 to 2018, were investigated. EOS was defined as the presence of a single potentially pathogenic bacterium grown from blood or cerebrospinal fluid in cultures drawn in any newborn infant within 72 hrs of birth. The changes in antimicrobial resistance of
resultsA total of 163 cases of EOS were identified, and
conclusionWe conclude that ESBL-producing multi-drug resistant
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.